Mara Aspinall is a healthcare industry pioneer and visionary who has built successful companies in all facets of the diagnostics industry. Mara also has extensive experience in the genetic disease industry. Mara was the President of Genzyme Genetics, the leading provider of genetic testing in the oncology and reproductive markets. Under Aspinall’s leadership, Genzyme Genetics set the industry standard for quality while growing at unprecedented to pace to become one of the world’s largest diagnostic labs. During her tenure as President and CEO of Ventana Medical Systems, Mara led the company to new financial success while launching several dozen new products and establishing itself as the industry’ leading developer and manufacturer of oncology companion diagnostics.
In addition to leading commercial organizations, Mara has led numerous educational initiatives in life sciences, including the creation of the School of Biomedical Diagnostics at Arizona State University, the first school in the world dedicated to diagnostics as an independent discipline. She was an active member of the Secretary of Health and Human Services committee on Genetics, Health and Society (SACGHS) under both the Bush and Obama administrations. Aspinall is a Director of Safeguard Scientific, (NYSE: SFE) a company providing growth capital for innovative healthcare and technology companies and Castle Biosciences.
Mara started her business career at the strategic consulting firm Bain & Company. She holds an MBA from Harvard Business School and a BA in International Relations from Tufts University.
Anne Morriss has an intimate understanding of the urgent need for better genetic information. After using a sperm donor, Anne gave birth to a son with a rare genetic condition that could have been prevented with GenePeeks technology.
Anne received her BA in American Studies from Brown University and an MBA from Harvard Business School. She has helped launch and grow multiple technology companies, with a focus on expanding entrepreneurship in developing economies. Anne served as a senior advisor with the OTF Group, founded the Concire Leadership Institute, and is the best-selling co-author of Uncommon Service: How to Win By Putting Customers at the Core of Your Business (Harvard Business Review Press).
Anne has appeared on 60 Minutes and CBS This Morning to discuss GenePeeks and its mission to protect future generations from disease. She is regularly invited to write and speak on the intersection of leadership, service and innovation. Anne is a frequent contributor to Harvard Business Review and has been featured in publications ranging from BBC News to the Boston Globe for her vision and impact as Co-Founder and CEO of GenePeeks.
Lee Silver holds a PhD from Harvard University and is a Princeton University professor emeritus of molecular biology. He has been elected a lifetime fellow of the American Association for the Advancement of Science and has received a National Institutes of Health MERIT award for outstanding research in genetics. Lee was a member of the New Jersey Bioethics Commission Task Force, and he has testified on reproductive and genetic technologies before U.S. Congressional and New York State Senate committees.
Lee has published over 200 research articles on genetics and computational modeling, as well as two of the leading academic genetic textbooks (Mouse Genetics: Concepts and Application and Genetics: From Genes to Genomes) and two popular science books (Challenging Nature and Remaking Eden). His thought leadership has been showcased on 60 Minutes, CBS This Morning, The Charlie Rose Show, 20/20, PBS, NBC, ABC News, Nightline, and NPR programs such as Intelligence Squared, OnPoint, and Radiolab.
Lee is the lead inventor on two issued patents (U.S. 8,620,594 and U.S. 8,895,629) for his method of generating a hypothetical progeny genome, which is the basis of the GenePeeks technology.
Over the course of his career, Matt Posard has held influential leadership roles at a number of market leading companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. During his nine years at Illumina, Matt held several key executive positions including senior leadership roles in Marketing, Global Sales, Translational and Consumer Genomics, and New and Emerging Markets. He built and led the team responsible for growing company sales to more than $1 billion in five years, drove global product launches of multiple clinical and consumer genomic applications, and established several new business units where he oversaw Commercial, Product Development, Business Development, Professional Services and Laboratory Operations.
He earned his Bachelor of Arts degree in Quantitative Economics and Decision Science from the University of California, San Diego.
Daniel Geffken has more than 22 years of experience in the life sciences industry, ranging from start-ups to publicly traded companies with $1 billion+ market capitalizations. He has served as COO or CFO of four publicly traded and four privately held companies, in addition to advising a wide range of biotechnology clients on firm-level strategy, operations and finance. Dan has raised more than $700 million in equity and debt securities, including one of the largest PIPEs in biotechnology history.
In addition to serving as the Chief Financial Officer at GenePeeks, Dan is the Founder and Managing Director of Danforth Advisors, a premier life sciences consulting firm. He serves on the Board of Directors for Alcobra Ltd., a biopharmaceutical company that completed its initial public offering in May 2013. He is also the former Co-Chairman of the Association of Bioscience Financial Officers (ABFO) and of the Finance Committee of the Massachusetts Biotechnology Council.
Dan has a B.S. in Economics from The Wharton School, University of Pennsylvania and an M.B.A. from Harvard Business School.
Melissa Starkey has nearly a decade of experience building strong commercial relationships in the women’s health industry. Prior to GenePeeks, Melissa spent three years as an IVF Specialist at Natera, working with reproductive endocrinologists and embryologists to integrate genetic screening into fertility clinic practices. Previously, Melissa was a Senior Sales Executive at Medical Diagnostics Laboratories, specializing in infectious disease testing for Women’s Health and Gynecology.
At GenePeeks, Melissa builds relationships with clinic partners by ensuring that their needs can be met with efficiency and care
Nigel Delaney has spent his career working on problems at the intersection of biology, statistical inference and computing. He holds a PhD in Evolutionary Genetics and an AM in Statistics from Harvard University where he held both a James Mills Peirce and National Science Foundation fellowship. His doctoral research used computational and experimental methods to study the effects of mutations, and he went on to study the consequences of deleterious genetic mutations while doing post-doctoral work at Massachusetts General Hospital and the Broad Institute.
He previously worked at Pacific Biosciences of California, where he built and led the internal tools group and developed a statistical model currently used for generating consensus sequencing data.
Kim Monroe has served in senior leadership roles at a wide range of innovative healthcare organizations, from early-stage firms to Fortune 500 companies. She has built her career on developing successful, high-impact partnerships, with a particular focus on institutions at the intersection of genetics and fertility including Genesis Genetics Institute and PGD by ART, now part of Cooper Surgical, Inc. At GenePeeks, Kim works to drive growth and develop strategic partnerships that benefit all stakeholders in the GenePeeks ecosystem.
Kim received her Bachelor’s Degree in Clinical Laboratory Technology from Webster University and completed her Medical Technology Internship at Washington University.
Carlos Borroto has over ten years of experience in building computational applications for laboratory data analysis. He has a Masters in Bioinformatics from Johns Hopkins University, with a concentration in computational genomics and gene expression analysis.
In his previous role as a Bioinformatics Analyst at BioReliance, Carlos managed the in-house UNIX infrastructure and development of scripting pipelines for NGS data analysis. As a Research Specialist at the University of Maryland, Carlos focused on projects pertaining to next-generation sequencing and microarray data.
From processor design to the creation and use of high-level scripting languages, Mike Hearing has a comprehensive understanding of computer systems. His expertise spans a variety of programming languages and technologies, including Python, SQL/NoSQL, C++, and CUDA. He is also well-versed in cryptography, machine learning, and distributed systems.
Mike has a B.S in Computer Engineering from the University of Pittsburgh. His work at GenePeeks is integral to the development of cutting-edge systems and platforms.
Velina applies her background in molecular biology, genetics, and data science to improve the design and implementation of the GenePeeks platform. Velina holds an A.B. in Biomedical Engineering from Harvard University with a minor in Computer Science.
Velina previously worked in the pharmacometrics group at Pfizer, focusing on pharmacological modeling and data visualization, and in a research and development role at Cocoon Biotech.
Mike Brown is an experienced product leader with a passion for bringing healthcare innovation to market. In his prior role at PatientsLikeMe, Mike worked with internal teams and external stakeholders to help chronically-ill patients track and share their data.
Mike has focused his career on leveraging technology to improve patient care. In addition to his product leadership work, Mike has played key roles in the design of medical devices and research on human biomechanics. He holds a B.S. in Biomedical Engineering and an M.S. in Engineering Management from Tufts University.
Jonathan Freidin applies his expertise in data science, machine learning, and software to the validation and optimization of GenePeeks' variant scoring system. He has held leadership roles in a range of technology industries, including cloud storage, renewable energy, artificial intelligence and silicon compilation.
Jonathan holds multiple patents and a BS in Applied and Engineering Physics from Cornell University. His work on Sky WindPower's flying electric generator was recognized by Time Magazine as one of the top 50 inventions of 2008.
A software engineer by trade, Mike has a range of experience in web development and bioinformatics. He has built applications using Python (with Django and Flask frameworks) and PHP, MongoDB, MySQL, and Neo4j databases.
Mike previously served as a Helios Scholar at the Translational Genomics Research Institute, where he applied network theory to modeling drug-gene interactions. He holds a B.S. in Computer Science from Arizona State University.
Juliana has brought her commitment to service to more than a decade of project management challenges in a broad array of industries, including eco-printing, healthcare, and not-for-profit institutions.
Juliana earned a B.A. in Public Relations from UNESP, a leading university in Brazil. She manages a range of projects at GenePeeks, including web and marketing coordination.
Max received an A.B in Ecology and Evolutionary Biology from Princeton University, with a focus in genetic analysis, linear algebra, and computer science. His skill set includes advanced Python programming, NumPy and SciPy for statistical data analysis, and Galaxy for intensive web-based genomics research.
At GenePeeks, Max furthers the theoretical development and implementation of the scientific algorithms with his work on machine learning, external data retrieval, and interactive visualization software for improved data interpretation.
Ari Silver applies his expertise in genetics towards developing and implementing novel statistical and genetic algorithms to simulate hypothetical progeny for GenePeeks. As the Director of Genetics, he also manages the bioinformatics pipeline for processing and analyzing next-generation sequencing data. Ari holds a BS in Biology from Brandeis University, with minors in Mathematics and Health: Science, Society, and Policy.
Ari previously served in a research capacity at Reprogenetics, where he performed functional analysis of regions of the human genome associated with autism and investigated the population structure of complex disease-causing mutations. He also worked as a lab technician at the California CryoBank, organizing and generating a computer database for tissue samples stored in liquid nitrogen.
Dalin Chan has extensive experience in the biotechnology field, and a laboratory skill set that includes DNA and RNA extraction, next-generation sequencing data analysis, targeted re-sequencing, Affymetrix microarray chips, and Illumina instruments.
Dalin has specialized in next-generation sequencing (NGS) for the past seven years. She graduated from Connecticut College with a BA in Biology and a focus on microbiology. She then gained her technical skill set from the Broad Institute and Partner's Healthcare. Dalin most recently served in the Translational Medicine group at Millennium Pharmaceuticals where she managed clinical NGS projects and applied cutting-edge biological technologies to oncology research.
Regine Lim is a certified genetic counselor with an MS in Genetic Counseling from the Mount Sinai School of Medicine. She has served patients at Long Island College Hospital in Brooklyn, NY, as well as in both research and industry environments, working closely with physicians and patients through a wide range of complex healthcare decisions.
Regine has dedicated her career to bridging the gaps between science and humanity, turning information into practical insight that can inform and empower people. Her research has been presented at the American Society of Reproductive Medicine and her volunteer work includes counseling to children with end-stage renal disease and other life-threatening illnesses.
Rebecca is energized by understanding client needs and delivering experiences that inspire loyalty and advocacy. Prior to GenePeeks, Rebecca served as the Director of Strategy at the digital agency Organic Spread Media (now One Public), where she worked with a team of designers and developers to create and deploy interactive experiences for leading consumer brands. Previously, she worked at the global agency Euro RSCG (now Havas), where she focused on the Sanofi Aventis client account.
Rebecca received a B.A in Anthropology from Princeton University. Her examination of behavioral trends gave her the foundation to examine stakeholder needs and optimize product design, web interactions, and service offerings.
Andrew received his BA in Finance from Lehigh University's College of Business and Economics. He is a graduate of GE's leadership development program, where he gained practical training and experience across multiple industries, including roles in energy, financial services, commercial real estate, corporate treasury, and capital headquarters.
At GenePeeks, Andrew plays a key role in investor relations and overseeing the company's financial and operational functions. He is responsible for translating the GenePeeks mission into a sustainable company model while facilitating the application and growth of its services.